CDNF and Parkinson disease: Although CDNF has now been successfully tested in rodent and NHP models of PD [20, 76, 84–86, 88, 103, 109–111, 117–119], as well as in Phase I-II clinical trial in patients with PD [23, 112], several challenges remain.